
Metware Biotechnology provides metabolomics research services and technology for life sciences and health. It uses a proprietary ultra-sensitivity high-throughput widely-targeted metabolomics platform, a curated metabolite database, and metabolite marker machine learning algorithms to enable detailed metabolite profiling. The company falls under B2B life sciences services, serving researchers in basic and clinical studies with global laboratories in the US and Asia. It combines core technology, data resources, and analytical methods to deliver scalable metabolomics solutions across institutions. Metware aims to support large-scale metabolomics projects and translational research through its technology and services.

Metware Biotechnology provides metabolomics research services and technology for life sciences and health. It uses a proprietary ultra-sensitivity high-throughput widely-targeted metabolomics platform, a curated metabolite database, and metabolite marker machine learning algorithms to enable detailed metabolite profiling. The company falls under B2B life sciences services, serving researchers in basic and clinical studies with global laboratories in the US and Asia. It combines core technology, data resources, and analytical methods to deliver scalable metabolomics solutions across institutions. Metware aims to support large-scale metabolomics projects and translational research through its technology and services.